Funding for this research was provided by:
Wellcome Trust (WT203132/Z/16/Z)
NIHR Oxford Biomedical Research Centre (IS-BRC-1215-20005)
Article History
Accepted: 21 December 2023
First Online: 12 January 2024
Declarations
:
: Julian Savulescu is a Partner Investigator on an Australian Research Council grant [LP190100841] which involves industry partnership from Illumina. He does not personally receive any funds from Illumina. Julian Savulescu is a Bioethics Committee consultant for Bayer and an Advisory Panel member for the Hevolution Foundation (2022-).